To the Editor: The article by Dr Phillips and colleagues,1 which estimated the cost-effectiveness of β-blocker therapy in all patients with myocardial infarction, adds to literature documenting poor health outcomes associated with underuse of β-blockers.2 Although we agree with the conclusions that increased β-blocker use would lead to impressive gains in health, we believe that the authors neglected to consider the costs of program implementation in their analysis.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.